Cargando…
TLR5 is a new reporter for triple‐negative breast cancer indicated by radioimmunoimaging and fluorescent staining
Triple‐negative breast cancer (TNBC) is a highly aggressive tumour that lacks marker for targeted diagnosis. Recently, it was reported that toll‐like receptor 5 (TLR5) was associated with some kind of tumours, especially in TNBC, but whether it could be used as a non‐invasive monitoring target is no...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850942/ https://www.ncbi.nlm.nih.gov/pubmed/31576678 http://dx.doi.org/10.1111/jcmm.14707 |